Gastrointestinal side effects (nausea, vomiting, diarrhea) occur more frequently with tirzepatide in some populations, though clinical data shows these are dose-dependent and often improve with slower titration
The Parenteral route of administration accounted for 67.45% of the market in 2025, owing to the established use of injectable GLP-1 agonists, superior bioavailability, extensive clinical validation, and widespread physician familiarity
March 20, 2026 / 14:31 IST Semaglutide Semaglutide patent expires in India on March 20, 2026
Adding that these drugs can reduce cholesterol levels, improve hemoglobin A1C (a marker of diabetes), as well as lower blood pressure and markers of inflammation to a greater extent
Diabetes Care (2015) 38(12):22419
they are rear fanged "Venomous", but even as adults you might get light headed at most if envenomed